Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Observational Study That Will Evaluate Prospectively Clinical and Surrogate Parameters That Are Affected in Infant Patients With Globoid Cell Leukodystrophy

NCT00983879 is registered in ClinicalTrials.gov with Zymenex A/S as lead sponsor.

NCT NCT00983879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Observational Study That Will Evaluate Prospectively Clinical and Surrogate Parameters That Are Affected in Infant Patients With Globoid Cell Leukodystrophy
Lead sponsor
Zymenex A/S
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile globoid cell leukodystrophy